One brother approved, one denied for same gene therapy

From NBC News.

The two boys both have Duchenne Muscular Dystrophy, a genetic disorder that typically has children wheelchair bound by the age of 12. Average life expectancy is less than 30. But there is a gene therapy that may slow or even halt the progress of the disease. Insurance approved one brother for the treatment, but then when the other applied for coverage a little while later, he was denied. NBC News’ Maggie Vespa reports for the series “The Cost of Denial.” 

For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews
» Subscribe to Here’s the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://apps.nbcnews.com/mobile
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Follow NBC News on Instagram: http://nbcnews.to/InstaNBC

#Healthcare #Health #MuscularDystrophy